Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Psyence Australia Pty Ltd
University of Colorado, Denver
Daiichi Sankyo
HealthPartners Institute
Mayo Clinic
Pfizer
OHSU Knight Cancer Institute
Memorial Sloan Kettering Cancer Center
Elevation Oncology
Optimal Health Research
Region Örebro County
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Exelixis
Universitair Ziekenhuis Brussel
University Health Network, Toronto
Convalife (Shanghai) Co., Ltd.
pharmaand GmbH
OncoNano Medicine, Inc.
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
Advanced Accelerator Applications
Tetra Bio-Pharma
University of Maryland, Baltimore
RenJi Hospital
Duke University
National University Hospital, Singapore
InSightec
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
AstraZeneca
Stanford University
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Arizona Oncology Services
National Center for Complementary and Integrative Health (NCCIH)
Hellenic Cooperative Oncology Group
National Center for Complementary and Integrative Health (NCCIH)